semaglutide vs tirzepatide side effects Tirzepatide: Which Is More Effective? Why You Might Tolerate One

PMCID: PMC2885294

Oral semaglutide potentially expands the treatment options for T2D patients particularly with renal or hepatic impairment, in whom options for oral glucose-lowering agents are limited

At NY Medical Weight Loss, we understand the challenges of achieving sustainable weight loss and offer advanced medical solutions tailored to your individual needs

GHK-Cu (copper peptide) GHK-Cu is a naturally occurring tripeptide that binds copper and plays a central role in tissue remodeling, wound healing, and hair follicle regulation

Key benefits Why people compare it 1 22.5% mean body weight reduction at 15mg in SURMOUNT-1 (N=2,539, 72 weeks) 2 Dual GIP/GLP-1 receptor activation for combined metabolic effects beyond single-agonist therapy 3 63% of participants at highest dose achieved at least 20% weight loss vs 1.3% placebo 4 Superior A1C reduction of 2.07-2.59% with up to 97% of diabetic participants reaching target 5 Outperformed semaglutide 1mg head-to-head in SURPASS-2 for both weight and glycemic endpoints 6 Enhanced adipose tissue lipid handling and fat redistribution via GIPR signaling 7 Significant improvements in triglycerides, blood pressure, and waist circumference across all doses 8 Once-weekly dosing supported by 120-hour half-life and C20 fatty diacid albumin binding Deep research Tirzepatide is a 39-amino-acid synthetic peptide with a molecular weight of 4,813.45 Da